Serkan Demir

Serkan Demir

Auto-generated profile, based on publicly available information

Serkan Demir

Neurology Department, University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2024 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
BOBilgin OZTURK
Bilgin OZTURK
Esra TaşkıranEsra Taşkıran
Esra Taşkıran
SDSerkan Demir
Serkan Demir
MTMeryem Aslı Tuncer
Meryem Aslı Tuncer
MKMurat Kürtüncü
Murat Kürtüncü
ŞBŞuayip Birinci
Şuayip Birinci
Background: Many studies on multiple sclerosis (MS) reveal different prevalence and epidemiologic results. Objectives: In this study, we aimed to determine the epidemiologic profile of MS using official health records in Turkey. Methods: Patients diagnosed with MS from the official health data of the Ministry of Health, representing the entire population of Turkey, were included in the study. Prevalence and incidence calculations were performed using the data on gender, age, year of birth, city of residence, and year of diagnosis. Results: As a result of the study, the number of patients with the ICD code G35 was determined as 201,061 and the number of patients with this code entered at least three times was determined as 82,225. The prevalence of MS in Turkey was calculated as 96.4 per 100,000 and the female/male ratio as 2.1/1. The incidence of MS in 2022 was 6.2 per 100,000 and the mean patient age was 43.1 ± 13.3 years (female: 43.0 ± 13.1 vs male: 43.2 ± 13.7) while the mean age at first diagnosis was 34.0 ± 13.0 (female: 33.6 ± 12.6 vs male: 34.9 ± 13.7). Conclusion: The research was conducted via Official Database of Turkey, which includes population of 85 million and provides valuable insights into the prevalence and incidence rates of this chronic disease.

20 October 2021 in American Journal of Physical Medicine & Rehabilitation
Verified
Journal Article
Closed access
TOTugba Ozsoy-Unubol
Tugba Ozsoy-Unubol
EAEmre Ata
Emre Ata
MCMuyesser Cavlak
Muyesser Cavlak
SDSerkan Demir
Serkan Demir
ZCZeynep Candan
Zeynep Candan
FYFigen Yilmaz
Figen Yilmaz
Objective: This study aims to evaluate and compare the effects of conventional and robot-assisted gait training (RAGT) programs on fatigue, mood, and quality of life in patients with multiple sclerosis who have fatigue. Methods: In this single-blinded, randomized controlled study, 37 patients with multiple sclerosis were randomized into two groups: RAGT (n = 18) and conventional gait training (n = 19). The RAGT group had gait training with RoboGait, whereas the conventional gait training group received conventional physiotherapist-assisted gait training. Outcome measures were the Fatigue Severity Scale, Hospital Anxiety Depression Scale, Multiple Sclerosis Quality of Life-54, Extended Disability Status Scale, Functional Ambulation Category, Berg Balance Test, and 6-min walk test. Results: Baseline demographic, clinic, and functional data were similar. Both groups showed improvements in the Fatigue Severity Scale, Hospital Anxiety Depression Scale–Depression, Multiple Sclerosis Quality of Life, Berg Balance Test, and 6-min walk test scores after treatment. Only the RAGT group showed an improvement in Hospital Anxiety Depression Scale–Anxiety score. The RAGT group had better Fatigue Severity Scale, and Hospital Anxiety Depression Scale scores. Conclusion: In combination with the standard rehabilitation program, both RAGT and conventional gait training are effective for multiple sclerosis. However, RAGT has superior effects in terms of fatigue, depression, and anxiety. Therefore, it may be preferred in multiple sclerosis patients who exhibit prominent symptoms of fatigue, depression, or anxiety.

27 December 2022 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
Ozge Gonul OnerOzge Gonul Oner
Ozge Gonul Oner
HGHasan Can Gudek
Hasan Can Gudek
OCOzdem Erturk Cetin
Ozdem Erturk Cetin
SDSerkan Demir
Serkan Demir
Objective: Botulinum toxin type A is widely used for the treatment of spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine, and also cosmetic purposes. Therapeutic use is commonly effective and safe. However, if toxin enters the vascular space and gets through to peripheral cholinergic nerve terminals, it may lead to iatrogenic botulism. Method: We presented a patient who is diagnosed as iatrogenic botulism and treated with antitoxin at the 15th day of the exposure. Results: After the antitoxin administration, dramatical response to the treatment was observed. Conclusions: In this report, we want to evaluate a new case of iatrogenic botulism and emphasize the importance of antitoxin administration regardless the timing of the exposure for patients with progressing paralysis.

20 March 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
CUCihat Uzunköprü
Cihat Uzunköprü
MTMelih Tütüncü
Melih Tütüncü
TGTUNCAY GÜNDÜZ
TUNCAY GÜNDÜZ
HGHaluk Gümüş
Haluk Gümüş
SŞSedat Şen
Sedat Şen
ASAksel Siva
Aksel Siva

1 January 2018 in Archives of Neuropsychiatry
Verified
Journal Article
Open access
SDSerkan Demir
Serkan Demir
Functional disorders due to multiple sclerosis are evaluated using rating scales. EDSS is a scant which is very inadequate in evaluating cognitive functions, is significantly limited in evaluating upper extremity functions and is highly difficult to repeat. Multiple Sclerosis Functional Composite (MSFC) is considered as a test that has been proposed in recent years in MS clinical trials and can overcome these negative features of EDSS. Three primary assessment methods were suggested for MSFC (9): 1) 25-step walking, 2) 9-Hole Peg test (9-HPT), and 3) Paced Auditory Serial Addition Test-3 (PASAT-3)

16 April 2024 in Journal of Evaluation in Clinical Practice
Verified
Journal Article
Closed access
EUEsra Uslu
Esra Uslu
AÖAysel Özsaban
Aysel Özsaban
ŞOŞahika Ocak
Şahika Ocak
ABAysun Bayram
Aysun Bayram
SDSerkan Demir
Serkan Demir